What can biotech companies learn from banking scandals?
A board stacked with well-known names but little hands-on knowledge suggests that governance is not a high priority and should ring warning bells for investors.
A board stacked with well-known names but little hands-on knowledge suggests that governance is not a high priority and should ring warning bells for investors.